463 results on '"Dixon, Simon R"'
Search Results
2. Cardiac allograft vasculopathy : the Green Lane Hospital experience 1987-1998
3. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
4. Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage
5. Institutional Variability in Patient Radiation Doses ≥5 Gy During Percutaneous Coronary Intervention
6. Disparate Impact of Ischemic Injury on Regional Wall Dysfunction in Acute Anterior vs Inferior Myocardial Infarction
7. OR2-1 | Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Post-Approval Study in SCAI SHOCK Stage E Patients
8. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure
9. Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
10. A Heart Gone Bananas: Allergy-Induced Coronary Vasospasm due to Banana (Kounis Syndrome)
11. C-8 | Analysis of Impella for Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Post-Approval Study by SCAI Shock Stage
12. Prediction and Analysis of Heart Diseases Using Heterogeneous Computing Platform
13. Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock
14. Comparison of the Use of Hemodynamic Support in Patients ≥80 Years Versus Patients
15. Impact of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention (from the PROTECT II Randomized Trial)
16. Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
17. Devices for Myocardial Preservation
18. D-20 | Novel Catheterization Laboratory Radiation Protection System Eliminates Need for Personal Lead Aprons
19. BS-400-07 REDEFINE-EP: A PROSPECTIVE, RANDOMIZED EVALUATION OF THE CONTROLRAD SYSTEM TO REDUCE RADIATION EXPOSURE DURING CARDIAC ELECTRONIC IMPLANTABLE DEVICE PROCEDURES
20. CI-523-03 REDEFINE-EP: A PROSPECTIVE, RANDOMIZED EVALUATION OF THE CONTROLRAD SYSTEM TO REDUCE RADIATION EXPOSURE DURING CARDIAC ELECTRONIC IMPLANTABLE DEVICE PROCEDURES
21. Present Status and Future Direction of NIRS-IVUS Multimodality Direct Coronary Imaging
22. Mortality in Patients With ST-Segment Elevation Myocardial Infarction Who Do Not Undergo Reperfusion
23. Analysis of Target Lesion Length Before Coronary Artery Stenting Using Angiography and Near-Infrared Spectroscopy Versus Angiography Alone
24. A Novel Catheterization Laboratory Radiation Shielding System: Results of Pre-Clinical Testing
25. P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
26. A Method to Compute Electrical Activity of the Heart: Prediction and Analysis of Heart Diseases Using Novel Comma-Z Classifier and Gpu Framework
27. Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions
28. The Year in Interventional Cardiology
29. Using simulation for teaching femoral arterial access: A multicentric collaboration
30. Radial PCI and the Obesity Paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
31. “Optimized” delivery of intracoronary supersaturated oxygen in acute anterior myocardial infarction: A feasibility and safety study
32. A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest
33. In-Stent Neoatherosclerosis and Distal Embolization: Lesion Architecture, Composition, and PCI Compression
34. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial): Initial U.S. Experience
35. Assessment of Plaque Composition with Near-Infrared Spectroscopy
36. The Year in Interventional Cardiology
37. Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)
38. The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
39. Comparative Safety of Bioabsorbable Polymer Everolimus-Eluting, Durable Polymer Everolimus-Eluting, and Durable Polymer Zotarolimus-Eluting Stents in Contemporary Clinical Practice
40. Disparate impact of severe aortic and mitral regurgitation on left ventricular dilation
41. Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): A Prospective, Randomized Trial of Intracoronary Hyperoxemic Reperfusion After Percutaneous Coronary Intervention
42. The Year in Interventional Cardiology
43. Predictors of Infarct Size After Primary Coronary Angioplasty in Acute Myocardial Infarction from Pooled Analysis from Four Contemporary Trials
44. Comparison of the Usefulness of Gadodiamide and Iodine Mixture Versus Iodinated Contrast Alone for Prevention of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
45. Mechanically supported PCI for ischemic cardiomyopathy reawakening of hibernating myocardium
46. Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery
47. The Year in Interventional Cardiology
48. The changing definition of contrast-induced nephropathy and its clinical implications: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
49. The Impact of Intra-Aortic Balloon Pump Weaning Protocols on In-Hospital Clinical Outcomes
50. Primary Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.